178 related articles for article (PubMed ID: 26601257)
1. Transcriptional regulation of APOBEC3 antiviral immunity through the CBF-β/RUNX axis.
Anderson BD; Harris RS
Sci Adv; 2015 Sep; 1(8):e1500296. PubMed ID: 26601257
[TBL] [Abstract][Full Text] [Related]
2. Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.
Wang J; Shaban NM; Land AM; Brown WL; Harris RS
J Virol; 2018 Jun; 92(12):. PubMed ID: 29618650
[TBL] [Abstract][Full Text] [Related]
3. Cellular requirements for bovine immunodeficiency virus Vif-mediated inactivation of bovine APOBEC3 proteins.
Zhang W; Wang H; Li Z; Liu X; Liu G; Harris RS; Yu XF
J Virol; 2014 Nov; 88(21):12528-40. PubMed ID: 25142583
[TBL] [Abstract][Full Text] [Related]
4. Core-binding factor subunit beta is not required for non-primate lentiviral Vif-mediated APOBEC3 degradation.
Ai Y; Zhu D; Wang C; Su C; Ma J; Ma J; Wang X
J Virol; 2014 Oct; 88(20):12112-22. PubMed ID: 25122780
[TBL] [Abstract][Full Text] [Related]
5. T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction.
Zhang W; Du J; Evans SL; Yu Y; Yu XF
Nature; 2011 Dec; 481(7381):376-9. PubMed ID: 22190036
[TBL] [Abstract][Full Text] [Related]
6. Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1.
Hultquist JF; Lengyel JA; Refsland EW; LaRue RS; Lackey L; Brown WL; Harris RS
J Virol; 2011 Nov; 85(21):11220-34. PubMed ID: 21835787
[TBL] [Abstract][Full Text] [Related]
7. A Naturally Occurring Domestic Cat APOBEC3 Variant Confers Resistance to Feline Immunodeficiency Virus Infection.
Yoshikawa R; Izumi T; Yamada E; Nakano Y; Misawa N; Ren F; Carpenter MA; Ikeda T; Münk C; Harris RS; Miyazawa T; Koyanagi Y; Sato K
J Virol; 2016 Jan; 90(1):474-85. PubMed ID: 26491161
[TBL] [Abstract][Full Text] [Related]
8. Feline Immunodeficiency Virus Evolutionarily Acquires Two Proteins, Vif and Protease, Capable of Antagonizing Feline APOBEC3.
Yoshikawa R; Takeuchi JS; Yamada E; Nakano Y; Misawa N; Kimura Y; Ren F; Miyazawa T; Koyanagi Y; Sato K
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331087
[TBL] [Abstract][Full Text] [Related]
9. Conserved Interaction of Lentiviral Vif Molecules with HIV-1 Gag and Differential Effects of Species-Specific Vif on Virus Production.
Zheng W; Ling L; Li Z; Wang H; Rui Y; Gao W; Wang S; Su X; Wei W; Yu XF
J Virol; 2017 Apr; 91(7):. PubMed ID: 28122978
[TBL] [Abstract][Full Text] [Related]
10. Natural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivity.
Refsland EW; Hultquist JF; Luengas EM; Ikeda T; Shaban NM; Law EK; Brown WL; Reilly C; Emerman M; Harris RS
PLoS Genet; 2014 Nov; 10(11):e1004761. PubMed ID: 25411794
[TBL] [Abstract][Full Text] [Related]
11. Vif determines the requirement for CBF-β in APOBEC3 degradation.
Yoshikawa R; Takeuchi JS; Yamada E; Nakano Y; Ren F; Tanaka H; Münk C; Harris RS; Miyazawa T; Koyanagi Y; Sato K
J Gen Virol; 2015 Apr; 96(Pt 4):887-892. PubMed ID: 25516542
[TBL] [Abstract][Full Text] [Related]
12. Stability of APOBEC3F in the Presence of the APOBEC3 Antagonist HIV-1 Vif Increases at the Expense of Co-Expressed APOBEC3H Haplotype I.
Yousefi M; Annan Sudarsan AK; Gaba A; Chelico L
Viruses; 2023 Feb; 15(2):. PubMed ID: 36851677
[TBL] [Abstract][Full Text] [Related]
13. Dual Functionality of HIV-1 Vif in APOBEC3 Counteraction and Cell Cycle Arrest.
Salamango DJ; Harris RS
Front Microbiol; 2020; 11():622012. PubMed ID: 33510734
[TBL] [Abstract][Full Text] [Related]
14. The Binding Interface between Human APOBEC3F and HIV-1 Vif Elucidated by Genetic and Computational Approaches.
Richards C; Albin JS; Demir Ö; Shaban NM; Luengas EM; Land AM; Anderson BD; Holten JR; Anderson JS; Harki DA; Amaro RE; Harris RS
Cell Rep; 2015 Dec; 13(9):1781-8. PubMed ID: 26628363
[TBL] [Abstract][Full Text] [Related]
15. Clues for two-step virion infectivity factor regulation by core binding factor beta.
Ai Y; Ma J; Wang X
J Gen Virol; 2017 May; 98(5):1113-1121. PubMed ID: 28516844
[TBL] [Abstract][Full Text] [Related]
16. Suppression of APOBEC3-mediated restriction of HIV-1 by Vif.
Feng Y; Baig TT; Love RP; Chelico L
Front Microbiol; 2014; 5():450. PubMed ID: 25206352
[TBL] [Abstract][Full Text] [Related]
17. Examination of the APOBEC3 Barrier to Cross Species Transmission of Primate Lentiviruses.
Gaba A; Flath B; Chelico L
Viruses; 2021 Jun; 13(6):. PubMed ID: 34200141
[TBL] [Abstract][Full Text] [Related]
18. Degradation of the cancer genomic DNA deaminase APOBEC3B by SIV Vif.
Land AM; Wang J; Law EK; Aberle R; Kirmaier A; Krupp A; Johnson WE; Harris RS
Oncotarget; 2015 Nov; 6(37):39969-79. PubMed ID: 26544511
[TBL] [Abstract][Full Text] [Related]
19. CBFß and HIV Infection.
Kim DY; Gross JD
Adv Exp Med Biol; 2017; 962():415-431. PubMed ID: 28299671
[TBL] [Abstract][Full Text] [Related]
20. Multiple lysines combined in HIV-1 Vif determines the responsiveness to CBF-β.
Ai Y; Ma J
Biochem Biophys Res Commun; 2015 Feb; 457(3):385-90. PubMed ID: 25582776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
